Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
94.54
USD
|
+3.10%
|
|
-2.73%
|
+1.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,498
|
1,834
|
1,475
|
1,587
|
1,486
|
1,529
|
-
|
-
|
Enterprise Value (EV)
1 |
1,447
|
1,834
|
1,475
|
1,587
|
1,486
|
1,529
|
1,529
|
1,529
|
P/E ratio
|
53.7
x
|
56.3
x
|
33.3
x
|
35
x
|
24.2
x
|
21.7
x
|
19.4
x
|
16.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.31
x
|
2.4
x
|
1.71
x
|
1.67
x
|
1.4
x
|
1.34
x
|
1.27
x
|
1.19
x
|
EV / Revenue
|
2.31
x
|
2.4
x
|
1.71
x
|
1.67
x
|
1.4
x
|
1.34
x
|
1.27
x
|
1.19
x
|
EV / EBITDA
|
25.5
x
|
23.8
x
|
15.1
x
|
15.6
x
|
12.3
x
|
11.8
x
|
10.9
x
|
10.2
x
|
EV / FCF
|
203
x
|
17.9
x
|
42.3
x
|
16.4
x
|
14.5
x
|
19.1
x
|
16.6
x
|
14.6
x
|
FCF Yield
|
0.49%
|
5.59%
|
2.36%
|
6.1%
|
6.92%
|
5.23%
|
6.02%
|
6.87%
|
Price to Book
|
3.19
x
|
3.57
x
|
2.6
x
|
2.53
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
15,412
|
15,660
|
15,773
|
15,950
|
16,005
|
16,169
|
-
|
-
|
Reference price
2 |
97.22
|
117.1
|
93.51
|
99.49
|
92.85
|
94.54
|
94.54
|
94.54
|
Announcement Date
|
3/17/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
648.8
|
764.8
|
864.5
|
951.1
|
1,059
|
1,144
|
1,206
|
1,285
|
EBITDA
1 |
58.7
|
76.91
|
97.66
|
101.5
|
121
|
129.4
|
139.7
|
149.2
|
EBIT
1 |
42.36
|
58.85
|
73.73
|
76.8
|
96.58
|
107.3
|
116.6
|
123.9
|
Operating Margin
|
6.53%
|
7.7%
|
8.53%
|
8.07%
|
9.12%
|
9.38%
|
9.67%
|
9.64%
|
Earnings before Tax (EBT)
1 |
33.17
|
41.94
|
60.4
|
60.17
|
81.33
|
94.74
|
106
|
119.3
|
Net income
1 |
25.24
|
33.13
|
45.13
|
46.02
|
62.52
|
71.53
|
79.98
|
89.72
|
Net margin
|
3.89%
|
4.33%
|
5.22%
|
4.84%
|
5.91%
|
6.25%
|
6.63%
|
6.98%
|
EPS
2 |
1.810
|
2.080
|
2.810
|
2.840
|
3.830
|
4.362
|
4.864
|
5.600
|
Free Cash Flow
1 |
7.398
|
102.6
|
34.84
|
96.81
|
102.8
|
80
|
92
|
105
|
FCF margin
|
1.14%
|
13.41%
|
4.03%
|
10.18%
|
9.71%
|
6.99%
|
7.63%
|
8.17%
|
FCF Conversion (EBITDA)
|
12.6%
|
133.38%
|
35.68%
|
95.4%
|
84.94%
|
61.81%
|
65.87%
|
70.4%
|
FCF Conversion (Net income)
|
29.31%
|
309.6%
|
77.21%
|
210.34%
|
164.43%
|
111.84%
|
115.04%
|
117.03%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/17/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
216.7
|
224.6
|
226.6
|
236.9
|
240.5
|
247
|
251.6
|
260
|
270.7
|
276.4
|
280.4
|
284.6
|
288.5
|
290.2
|
294.7
|
EBITDA
1 |
24.87
|
26.71
|
22.41
|
25.1
|
25.72
|
28.25
|
26.04
|
28.3
|
30.86
|
34.26
|
30.31
|
31.53
|
32.67
|
34.9
|
33.01
|
EBIT
1 |
19.13
|
20.48
|
16.4
|
18.81
|
19.5
|
22.08
|
19.95
|
24.92
|
24.67
|
28.09
|
24.75
|
26.09
|
27.01
|
29.32
|
26.03
|
Operating Margin
|
8.83%
|
9.12%
|
7.24%
|
7.94%
|
8.11%
|
8.94%
|
7.93%
|
9.58%
|
9.11%
|
10.16%
|
8.83%
|
9.17%
|
9.36%
|
10.1%
|
8.83%
|
Earnings before Tax (EBT)
1 |
15.78
|
17.82
|
11.75
|
15.02
|
15.13
|
18.28
|
16.25
|
19.5
|
20.22
|
25.35
|
21.28
|
22.94
|
23.79
|
26.37
|
24.37
|
Net income
1 |
11.58
|
13.06
|
8.47
|
11.25
|
11.54
|
14.76
|
12.68
|
14.85
|
15.41
|
19.58
|
16.15
|
17.26
|
17.91
|
20.2
|
18.36
|
Net margin
|
5.34%
|
5.81%
|
3.74%
|
4.75%
|
4.8%
|
5.98%
|
5.04%
|
5.71%
|
5.69%
|
7.08%
|
5.76%
|
6.06%
|
6.21%
|
6.96%
|
6.23%
|
EPS
2 |
0.7200
|
0.8100
|
0.5300
|
0.7000
|
0.7100
|
0.9100
|
0.7800
|
0.9100
|
0.9500
|
1.200
|
0.9860
|
1.054
|
1.090
|
1.230
|
1.120
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/1/21
|
2/24/22
|
5/2/22
|
8/1/22
|
10/31/22
|
2/27/23
|
5/1/23
|
7/31/23
|
10/30/23
|
2/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
51.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
7.4
|
103
|
34.8
|
96.8
|
103
|
80
|
92
|
105
|
ROE (net income / shareholders' equity)
|
6.78%
|
9.88%
|
10.7%
|
9.99%
|
9.33%
|
9.92%
|
11%
|
11%
|
ROA (Net income/ Total Assets)
|
5.13%
|
6.43%
|
4.9%
|
6.4%
|
-
|
-
|
-
|
-
|
Assets
1 |
492.4
|
515.6
|
920.1
|
719.4
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
30.50
|
32.80
|
36.00
|
39.30
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
6.500
|
6.880
|
6.180
|
6.440
|
-
|
Capex
1 |
4.62
|
6.83
|
4.65
|
8.3
|
9.45
|
11
|
13.2
|
-
|
Capex / Sales
|
0.71%
|
0.89%
|
0.54%
|
0.87%
|
0.89%
|
0.96%
|
1.09%
|
-
|
Announcement Date
|
3/17/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Last Close Price
94.54
USD Average target price
105.4
USD Spread / Average Target +11.52% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.82% | 1.53B | | -3.44% | 3B | | 0.00% | 1.81B | | +49.28% | 624M | | -3.09% | 503M | | -35.42% | 368M | | -34.25% | 139M | | -13.04% | 136M | | +1.92% | 67.7M |
Home Healthcare Services
|